Authors
Fei Sun, Jianqin Yan, Zhihong Sun, Zijian Zhao, Xiaolu Dong, Chaolong Liu, Yong Sun, Xianwen Wang
Published in
Acta biomaterialia. Nov 14, 2026. Epub Nov 14, 2026.
Abstract
The blood-brain barrier (BBB) and blood-brain tumor barrier (BBTB) severely limited drug delivery into the brain, while aberrant aerobic glycolysis in the tumor microenvironment caused excessive lactate accumulation and drove immunosuppression. These factors together constituted the core obstacles to glioblastoma (GBM) therapy. From the perspective of metabolism-immune crosstalk, we engineered a brain‑targeted nucleic acid nanosphere (TE@siP‑DNS/DOX) featuring high BBB/BBTB penetrability, which orchestrated a "triple‑linked" strategy integrating glycolysis blockade, immune microenvironment remodeling, and synergistic therapeutic potentiation. The nanosphere was constructed with a self‑assembled core of PKM2‑targeting siRNA and framework nucleic acids loaded with doxorubicin (DOX), shielded by a biomimetic shell of T7 peptide‑modified macrophage extracellular vesicles. Leveraging transcytosis and T7‑mediated active targeting, TE@siP‑DNS/DOX efficiently traversed the barriers and preferentially accumulated at tumor sites. DOX simultaneously provoked chemotherapy and immunogenic cell death, igniting robust CD8⁺ T cell‑mediated antitumor immunity, whereas siRNA‑mediated PKM2 silencing curtailed glycolysis, lessened lactate production, rewired metabolic circuitry, and forced macrophage polarization toward the M1 antitumor phenotype, thereby dismantling the immunosuppressive tumor microenvironment (iTME). Transcriptomic analysis further confirmed that metabolic and immune-related pathways were significantly enriched following TE@siP-DNS/DOX treatment, providing transcriptional evidence for its dual modulation of the metabolic-immune feedback loop. In vivo studies substantiated that TE@siP‑DNS/DOX markedly inhibited tumor growth and prolonged survival in orthotopic GBM-bearing mice. Collectively, this nanoplatform, through a synergistic feedback loop integrating metabolic regulation and immune activation, provides a good therapeutic strategy and research paradigm for enhanced glioma therapy. STATEMENT OF SIGNIFICANCE: Glioblastoma therapy is impeded by a multifaceted barrier system encompassing the blood-brain barrier, metabolic dysregulation, lactate accumulation, and immunosuppression. Here, we engineered a brain-targeted nucleic acid nanosphere that integrates glycolysis blockade, immune remodeling, and chemotherapeutic sensitization via a single platform. By combining PKM2 silencing with doxorubicin-loaded framework nucleic acids and T7-modified macrophage vesicles, the nanosphere achieves efficient barrier penetration, lactate reduction, M1 macrophage repolarization, and immunogenic cell death. This metabolism-immune feedback loop synergistically suppresses orthotopic tumors and extends survival. Our study provides a paradigm for treating brain tumors through concurrent metabolic reprogramming and antitumor immunity, offering a translatable strategy for overcoming therapy resistance in glioblastoma.
PMID:
43034028
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 17
- Comments 0